GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation for loss of share certificate is attached herewith.14-12-2023
GUFIC BIOSCIENCES LTD. - 509079 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation for loss of share certificate is attached herewith.GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
The written transcript of the Earnings Conference Call held on November 17, 2023 at 04:30 PM has been uploaded on the Company''s website.GUFIC BIOSCIENCES LTD. - 509079 - Intimation Of Incorporation Of Subsidiary Company
Intimation of incorporation of Subsidiary Company is attached herewith.GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Audio Call Recording of the Earnings Conference Call held on November 17, 2023 at 4:30 p.m. has been uploaded on the Company's website and can be accessed through the link: http://gufic.com/Notice/AUDIORECORDING_17112023.mp3 Written transcript of the same will be submitted in due course.GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Investor Presentation on Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023.GUFIC BIOSCIENCES LTD. - 509079 - Clarification On Increase In Volume Of Security
With reference to your email bearing Ref. No. L/SURV/ONL/PV/NP/2023-2024/420 dated November 17, 2023 seeking clarification on significant increase in the volume of security across Exchanges in the recent past, please find attached herewith our response for the sameGUFIC BIOSCIENCES LTD. - 509079 - Clarification sought from Gufic Biosciences Ltd
The Exchange has sought clarification from Gufic Biosciences Ltd on November 17, 2023, with reference to Movement in Volume.The reply is awaited.GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Company will host an Earnings Conference Call for Investors/Analysts on Friday, November 17, 2023 at 4:30 p.m. (IST), during which officials of the Company will discuss the business background/prospects and financial performance of the Company and take questions. The details of the Earnings Conference Call are mentioned in the Call Invite enclosed herewith.GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the Copies of Newspaper advertisement of extract of unaudited financial results of the Company for the quarter and half year ended September 30, 2023 published today i.e. November 10, 2023 in Business Standard (All Edition in English language) and Mumbai Lakshadeep (Mumbai Edition in Marathi langauge)GUFIC BIOSCIENCES LTD. - 509079 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023
Please find attached herewith Unaudited Standalone and Consolidated Financial Results for the Quarter and half year ended September 30, 2023